the Du Pont Axial Separation Technology (AST) system, which permanently separates a blood specimen into serum or plasma and cells in 1 mm. Although bar-coding and computerization have improved some
(axially). We believe the rapid separation of blood by the AST system has the potential to substantially reduce preanalytical specimen handling time. Although bar-coding and computerization have improved some The APC is an evacuated plastic blood tube designed to draw 7.0 mL of blood through a rubber draw stopper recessed in one end of the vial (Fig. 1) . The tube is constructed of a plastic with sufficient barrier properties to maintain a vacuum for >2 years. A removable overcap stopper at the other end allows easy sample removal. The APC is used with standard blood-collection needles and holders. Outside of the draw stopper is a wick pad that absorbs the blood drop usually present on the tip of the needle during APC withdrawal.
The location of the draw stopper and overcap stopper at opposite ends of the APC prevents contamination of the probe or sampling pipet with exterior blood. Once filled with blood, the APCs are placed on the input tray of the ASM, which automatically and continuously processes the samples in -1 mm each, depending on draw volume and hematocrit of the blood sample.
As described elsewhere by Estey and Felder [3] , the principle of operation is the rotation of the APC about its own longitudinal axis. This separates the blood into concentric cylinders of gas, fluid (plasma or serum), and cells (or clot). While the APC is spinning, a probe pierces the overcap and pushes the plastic separator down the length of the container. The separator is designed to allow air and serum/plasma to pass through it; thus, as the separator is moved down the APC, serum/plasma moves through the central channel of the separator.
When the sensor detects cellular components in the transfer inlet region, the probe direction is reversed. The probe is withdrawn through a self-sealing rubber component of the stopper overcap and the APC exits the ASM at the same time as the next APC is taken into the instrument.
The APC now consists of two compartments: the serum/plasma in the upper chamber is permanently isolated from the cellular contents at the bottom of the tube by The bottom of the tube has been designed to fit all common venipuncture needle holders and the primary label contains an arrow that clearly marks the "draw end." To prevent accidental sampling through the top of the tube, the overcap/separator end has been slightly enlarged so it cannot be inserted into a standard needle holder. The overcap minimizes aerosols, and the self-sealing butyl rubber stopper is easily penetrable should "through-stopper" sampling be desired. Paired samples (n 48 serum pairs, n = 50 plasma pairs) were transported to the laboratory with APCs placed in a horizontal position for the serum sample. Serum samples were allowed to clot before processing.
BD samples were centrifuged in a Beckman GPR centrifuge (Beckman Instruments, Brea, CA) at 3000g for 10 mm. APC samples were processed in the ASM. APC samples and to evaluate the significance of differences in means between the first BD and APC tubes drawn (see Table 3 , later).
Effect of clot angle on LD increases. Blood was collected from healthy volunteers who had given consent as above, but with different draw volumes, achieved by removing the APC prematurely from the needle. The draw volumes were calculated from the weight of the APC after filling. APCs from the same donor were positioned vertically, horizontally, and at 45#{176}; allowed to clot for 30 mm; and then processed in the ASM. Tables  1 and 2 summarize the linear regression data for the paired BD and APC samples. A small negative bias (BD <APC)
Results
was observed for LD in serum. For serum pairs, the difference between the BD and APC samples was statistically significant (P <0.05) for alanine aminotransferase, aspartate aminotransferase, cholesterol, C02, glucose, LD, sodium, triglycerides, and urate. For plasma pairs significant differences were seen for alkaline phosphatase, chloride, cholesterol, direct bilirubin, glucose, LD, potassium, total bilirubin, total protein, triglycerides, and urate. Table 3 summarizes ANOVA resultsfor plasma analytes from the volunteers who underwent multiple sample procurement. For the BD tubes (first and last tubes collected from each subject), statistically significant differences (P <0.05) were seen for albumin, CO2, and total protein. No significant differences were observed between the APC samples (2nd to 6th tubes collected). ANOVA was also performed to compare the mean results from the first BD sample with the first APC sample (Table 3 );no differences in chemistry results were seen.In the first few volunteers, aspartate aminotransferase was 5-10 U/L higher in the BD samples than in the APC. These samples had been centrifuged for 5 mm at 3000g. No such effect was seen when the BD samples were centrifuged for 10 mm at 3000g.
During initial development and evaluations,occasionally large discordances in LD values were observed in some serum pairs. Fig. 2 Sample volume in the tube also affected the measured LD, the greatest increase in LD being observed when a sample with only 2.5 mL of blood was clotted vertically.
Discussion
The commercial implementation of the axial separation concept by Du Pont Canada offersa unique approach to decreasingthe time required to permanently separate whole blood. The process of blood separation requires blood cell migration into the pellet as well as fluid flow out of the pellet. The speed of the cells isproportionalto the g-force applied, which is a function of the radial position of the individual blood cells. Thus, the time required to separate the cells from the serum or plasma is controlled by g-force and distance the cells must travel. In conventional centrifugation, the cells must travel (on average) one-half the distance along the container's length, or -50 mm in a 100-mm-long tube. In axial separation, the cells move radially from the gas/fluid interface to the pellet, a distance of -2 mm. This fact alone accounts for the 10-fold faster separation of blood processed axially.
We tested the AST system to determine 
Urea, mmol/L Mean (and SE). phlebotomy staff were initially skeptical when instructed to draw blood through the bottom of the tube; however, they had no difficulty in adapting to these new tubes. The location of the draw stopper at the bottom of the tube raised the possibility of rack and bench-top contamination by dried blood, which usually forms on draw stoppers after removal of the tube from the needle. However, in the APCs the clotted blood was held in the wick pad and did not flakeoff.When we tested the APCs in conventional centrifugesthey did not leak blood through the draw stopper end. Because the entire overcap/ separator assembly could be removed manually, we could access the serum or plasma in the same manner as for standard blood-collection tubes. The tubes withstood a fall from the bench to the floorwithout breakage,and the inertplastic separator alleviated any adsorption concerns previously reported for gel barriers [8] .
During development of the ASM, we noted thatoccasionally discordantLD valueswere observed in some serum pairs. This phenomenon was hypothesized to resultfrom leakage of LD from platelets when the clotwas stretchedduring axialspin. During conventional centrifugation, the clot undergoes only compressive forces,and conventional centrifugation of APCs did not resultin increased LD values (data not presented). However, when a sample has been clotted in the vertical position, the clotisforcedto stretchwhen itisspun in the axial or horizontalposition.When samples are clottedin the horizontal position, however, the clot extends the full length of the APC and therefore experiencesminimal stretchduring axial processing.To confirm this hypothesis,we investigatedthe effectof "clotangle" on LD increase. As shown in Fig. 2 , the more the angle atwhich the sample was allowed to clotdiffered from horizontal, the higher the LD increase compared with conventional centrifugation. This LD increase was also a function of the volume of blood in the tube. The greatest increase in LD was observed when a sample was clotted vertically with only 2.5 mL of blood.
Our studmes to date suggest that LD increases are a result of platelet lysis and liberation of the enzyme during axial processing. The magnitude of this LD increase appears to be a function of the angle and rate of clot formation and the number of platelets incorporated into the clot. Platelet release of LD could be minimized by transporting and clotting serum samples in the horizontal position. Functionally, our blood procurement and accessioning staff did not find these restrictions problematic.
Additionalstudiesare ongoing to study the factorsaffecting LD release from platelets and to further investigate the behavior of clotswhen they are "compressed" or "stretched."
The demonstrated chemical equivalency of the samples obtained with the Du Pont AST system has clearedthe way for clinical use of thissystem and forevaluationof the impact of the system on overallTAT in variousclinical settings. We believe serial processingof samples through axialseparationwilloffer (0 
